SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-010025
Filing Date
2016-05-13
Accepted
2016-05-13 09:01:03
Documents
32
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051316.htm 10-Q 157146
2 EXHIBIT 31.1 exh_311.htm EX-31.1 8508
3 EXHIBIT 31.2 exh_312.htm EX-31.2 8566
4 EXHIBIT 32 exh_32.htm EX-32 3811
  Complete submission text file 0001171843-16-010025.txt   1315685

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE caps-20160331.xml EX-101.INS 153025
6 XBRL SCHEMA FILE caps-20160331.xsd EX-101.SCH 21336
7 XBRL CALCULATION FILE caps-20160331_cal.xml EX-101.CAL 19677
8 XBRL DEFINITION FILE caps-20160331_def.xml EX-101.DEF 104535
9 XBRL LABEL FILE caps-20160331_lab.xml EX-101.LAB 137923
10 XBRL PRESENTATION FILE caps-20160331_pre.xml EX-101.PRE 120397
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 161646034
SIC: 2834 Pharmaceutical Preparations